Symptom subtypes of obsessive-compulsive disorder: Are they relevant for treatment?

Australian and New Zealand Journal of Psychiatry

Volumn 42, Issue 8, 2008, Pages 651-661

  Starcevic, Vladan ^a,b   Brakoulias, Vlasios ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NEPEAN HOSPITAL   (Australia)

Author keywords

Cognitive behaviour therapy; Exposure and response prevention; Obsessive compulsive disorder; Serotonin re uptake inhibitors; Subtypes

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; NEUROLEPTIC AGENT; PAROXETINE; PHENELZINE; SEROTONIN UPTAKE INHIBITOR;

BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; COMBINATION CHEMOTHERAPY; DISEASE SEVERITY; HUMAN; MEDICAL DECISION MAKING; MONOTHERAPY; MOTIVATION; OBSESSIVE COMPULSIVE DISORDER; RELIGION; REVIEW; SEXUAL BEHAVIOR; SYMPTOM; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIPSYCHOTIC AGENTS; COGNITIVE THERAPY; EATING; EVOKED POTENTIALS; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; QUESTIONNAIRES; RELIGION; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SEXUAL BEHAVIOR; STEREOTYPED BEHAVIOR;

EID: 47949109299     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1080/00048670802203442     Document Type: Review

References (109)

1. van Oppen, P., Hoekstra, RJ and Emmelkamp, PMG. (1995) The structure of obsessive-compulsive symptoms. Behav Res Ther, 33, pp. 379-390.
2. Kyrios, M., Bhar, S. and Wade, D. (1996) The assessment of obsessive-compulsive phenomena: Psychometric and normative data on the Padua Inventory from an Australian non-clinical sample. Behav Res Ther, 34, pp. 85-95.
3. Leckman, JF, Grice, DE Boardman, J. et al. (1997) Symptoms of obsessive-compulsive disorder. Am J Psychiatry, 154, pp. 911-917.
4. Calamari, JE, Wiegartz, RS and Janeck, AS. (1999) Obsessive-compulsive subgroups: A symptom-based clustering approach. Behav Res Ther, 37, pp. 113-125.
5. Mataix-Cols, D., Rauch, SL, Manzo, PA, Jenike, MA and Baer, L. (1999) Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry, 156, pp. 1409-1416.
6. Summerfeldt, LJ, Richter, MA, Antony, MM and Swinson, RP. (1999) Symptom structure in obsessive-compulsive disorder: A confirmatory factor-analytic study. Behav Res Ther, 37, pp. 297-311.
7. Abramowitz, JS, Franklin, ME, Schwartz, SA and Furr, JM. (2003) Symptom presentation and outcome of cognitive behavioral therapy for obsessive-compulsive disorder. J Consult Clin Psychol, 71, pp. 1049-1057.
8. Feinstein, SB, Fallon, BA, Petkova, E. and Liebowitz, MR. (2003) Item-by-item factor analysis of the Yale-Brown Obsessive Compulsive Scale Symptom Checklist. J Neuropsychiatry Clin Neurosci, 15, pp. 187-193.
9. Calamari, JE, Wiegartz, RS Riemann, BC et al. (2004) Obsessive-compulsive disorder subtypes: An attempted replication and extension of a symptom-based taxonomy. Behav Res Ther, 42, pp. 647-670.
10. Denys, D., de Geus, F., van Megen, HJGM and Westenberg, HGM. (2004) Symptom dimensions in obsessive-compulsive disorder: Factor analysis on a clinician-rated scale and a self-report measure. Psychopathol, 37, pp. 181-189.
11. Stein, DJ, Andersen, EW and Overo, KF. (2007) Response of symptom dimensions in obsessive-compulsive disorder to treatment with citalopram or placebo. Rev Bras Psiquiatr, 29, pp. 303-307.
12. Matsunaga, H., Maebayashi, K. Hayashida, K. et al. (2008) Symptom structure in Japanese patients with obsessive-compulsive disorder. Am J Psychiatry, 165, pp. 251-253.
13. Rasmussen, SA and Eisen, JL. (1992) The epidemiology and clinical features of obsessive-compulsive disorder. Psychiatr Clin North Am, 15, pp. 743-758.
14. Mataix-Cols, D., Rauch, SL Baer, L. et al. (2002) Symptom stability in adult obsessive-compulsive disorder: Data from a naturalistic two-year follow-up study. Am J Psychiatry, 159, pp. 263-268.
15. Rufer, M., Grothusen, A., Mass, R., Peter, H. and Hand, I. (2005) Temporal stability of symptom dimensions in adult patients with obsessive-compulsive disorder. J Affect Disord, 88, pp. 99-102.
16. National Institute for Health and Clinical Excellence (NICE) Guidelines (2005) National Institute for Health and Clinical Excellence, London
17. American Psychiatric Association (2007) Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry, 164, pp. 1-56.
18. Goodman, WK, Price, LH Rasmussen, SA et al. (1989) The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability. Arch Gen Psychiatry, 46, pp. 1006-1011.
19. Eisen, JL, Goodman, WK Keller, MB et al. (1999) Patterns of remission and relapse in obsessive-compulsive disorder: A 2-year prospective study. J Clin Psychiatry, 60, pp. 346-351.
20. Schruers, K., Koning, K., Luermans, J., Haack, MJ and Griez, E. (2005) Obsessive-compulsive disorder: A critical review of therapeutic perspectives. Acta Psychiatr Scand, 111, pp. 261-271.
21. Ball, SG, Baer, L. and Otto, MW. (1996) Symptom subtypes of obsessive-compulsive disorder in behavioral treatment studies: A quantitative review. Behav Res Ther, 34, pp. 47-51.
22. Mataix-Cols, D., Marks, IM, Greist, JH, Kobak, KA and Baer, L. (2002) Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: Results from a controlled trial. Psychother Psychosom, 71, pp. 255-262.
23. Rufer, M., Fricke, S., Moritz, S., Kloss, M. and Hand, I. (2006) Symptom dimensions in obsessive-compulsive disorder: Prediction of cognitive-behavior therapy outcome. Acta Psychiatr Scand, 113, pp. 440-446.
24. Black, DW, Monahan, P., Gable, J., Blum, N., Clancy, G. and Baker, P. (1998) Hoarding and treatment response in 38 nondepressed subjects with obsessive-compulsive disorder. J Clin Psychiatry, 59, pp. 420-425.
25. Christensen, H., Hadzi-Pavlovic, D., Andrews, G. and Mattick, R. (1987) Behavior therapy and tricyclic medication in the treatment of obsessive-compulsive disorder: A quantitative review. J Consult Clin Psychol, 55, pp. 701-711.
26. Alonso, P., Menchon, JM Pifarre, J. et al. (2001) Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. J Clin Psychiatry, 62, pp. 535-540.
27. Buchanan, AW, Meng, KS and Marks, IM. (1996) What predicts improvement and compliance during the behavioral treatment of obsessive compulsive disorder?. Anxiety, 2, pp. 22-27.
28. Basoglu, M., Lax, T., Kasvikis, Y. and Marks, IM. (1988) Predictors of improvement in obsessive-compulsive disorder. J Anxiety Disord, 2, pp. 299-317.
29. Foa, EB and Goldstein, A. (1978) Continuous exposure and complete response prevention of obsessive-compulsive neurosis. Behav Ther, 9, pp. 821-829.
30. Drummond, LM. (1993) The treatment of severe, chronic, resistant obsessive-compulsive disorder. An evaluation of an in-patient programme using behavioural psychotherapy in combination with other treatments. Br J Psychiatry, 163, pp. 223-229.
31. Winsberg, ME, Cassic, KS and Koran, LM. (1999) Hoarding in obsessive-compulsive disorder: A report of 20 cases. J Clin Psychiatry, 60, pp. 591-597.
32. Erzegovesi, S., Cavallini, MC, Cavedini, P., Diaferia, G., Locatelli, M. and Bellodi, L. (2001) Clinical predictors of drug response in obsessive-compulsive disorder. J Clin Psychopharmacol, 21, pp. 488-492.
33. Shetti, CN, Reddy, YCJ Kandavel, T. et al. (2005) Clinical predictors of drug nonresponse in obsessive-compulsive disorder. J Clin Psychiatry, 66, pp. 1517-1523.
34. Saxena, S., Brody, AL, Maidment, KM and Baxter, LR. (2007) Paroxetine treatment of compulsive hoarding. J Psychiatr Res, 41, pp. 481-487.
35. DeVeaugh-Geiss, J., Katz, R., Landau, P., Goodman, W. and Rasmussen, S. (1990) Clinical predictors of treatment response in obsessive-compulsive disorder: Exploratory analyses from multicenter trials of clomipramine. Psychopharmacol Bull, 26, pp. 54-59.
36. Ackerman, DL, Greenland, S., Bystritsky, A., Morgenstern, H. and Katz, RJ. (1994) Predictors of treatment response in obsessive-compulsive disorder: Multivariate analyses from a multicenter trial of clomipramine. J Clin Psychopharmacol, 14, pp. 247-254.
37. Ackerman, DL, Greenland, S. and Bystritsky, A. (1998) Clinical characteristics of response to fluoxetine treatment of obsessive-compulsive disorder. J Clin Psychopharmacol, 18, pp. 185-192.
38. Denys, D., Burger, H., van Megen, H., de Geus, F. and Westenberg, H. (2003) A score for predicting response to pharmacotherapy in obsessive-compulsive disorder. Int Clin Psychopharmacol, 18, pp. 315-322.
39. Jenike, MA, Baer, L., Minichiello, WE, Rauch, SL and Buttolph, ML. (1997) Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder. Am J Psychiatry, 154, pp. 1261-1264.
40. Shavitt, RG, Belotto, C. Curi, M. et al. (2006) Clinical features associated with treatment response in obsessive-compulsive disorder. Compr Psychiatry, 47, pp. 276-281.
41. Himle, JA, Fischer, DJ, Van Etten, ML, Janeck, AS and Hanna, GL. (2003) Group behavioral therapy for adolescents with tic-related and non-tic-related obsessive-compulsive disorder. Depress Anxiety, 17, pp. 73-77.
42. Whittal, ML, Thordarson, DS and McLean, PD. (2005) Treatment of obsessive-compulsive disorder: Cognitive behavior therapy vs exposure and response prevention. Behav Res Ther, 43, pp. 1559-1576.
43. Ravizza, L., Barzega, G., Bellino, S., Bogetto, F. and Maina, G. (1995) Predictors of drug treatment response in obsessive-compulsive disorder. J Clin Psychiatry, 56, pp. 368-373.
44. Catapano, F., Perris, F. Masella, M. et al. (2006) Obsessive-compulsive disorder: A 3-year prospective follow-up study of patients treated with serotonin reuptake inhibitors. OCD follow-up study. J Psychiatr Res, 40, pp. 502-510.
45. Alarcon, RD, Libb, JW and Spitler, D. (1993) A predictive study of obsessive-compulsive disorder response to clomipramine. J Clin Psychopharmacol, 13, pp. 210-213.
46. Saxena, S., Maidment, KM Vapnik, T. et al. (2002) Obsessive-compulsive hoarding: Symptom severity and response to multimodal treatment. J Clin Psychiatry, 63, pp. 21-27.
47. Hohagen, F., Winkelmann, G. Rasche-Rauchle, H. et al. (1998) Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo: Results of a multicentre study. Br J Psychiatry, 35, pp. 71-78.
48. Keijsers, GPJ, Hoogduin, CAL and Schaap, CPDR. (1994) Predictors of treatment outcome in the behavioural treatment of obsessive-compulsive disorder. Br J Psychiatry, 165, pp. 781-786.
49. Franklin, ME, Abramowitz, JS, Kozak, MJ, Levitt, JT and Foa, EB. (2000) Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: Randomized compared with nonrandomized samples. J Consult Clin Psychol, 68, pp. 594-602.
50. Stein, DJ, Montgomery, SA, Kasper, S. and Tanghoj, P. (2001) Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder. Int Clin Psychopharmacol, 16, pp. 357-361.
51. Hollander, E., Bienstock, CA Koran, LM et al. (2002) Refractory obsessive-compulsive disorder: State-of-the-art treatment. J Clin Psychiatry, 63, pp. 20-29.
52. Rosario-Campos, MC, Leckman, JF Mercadante, MT et al. (2001) Adults with early-onset obsessive-compulsive disorder. Am J Psychiatry, 158, pp. 1899-1903.
53. Kozak, MJ and Foa, EB. (1994) Obsessions, overvalued ideas, and delusions in obsessive-compulsive disorder. Behav Res Ther, 32, pp. 343-353.
54. Foa, EB, Abramowitz, JS, Franklin, ME and Kozak, MJ. (1999) Feared consequences, fixity of belief, and treatment outcome in patients with obsessive-compulsive disorder. Behav Ther, 30, pp. 717-724.
55. Kishore, VR, Samar, R., Reddy, YCJ, Chandrasekhar, CR and Thennarasu, K. (2004) Clinical characteristics and treatment response in poor and good insight obsessive-compulsive disorder. Eur Psychiatry, 19, pp. 202-208.
56. Minichiello, W., Baer, L. and Jenike, MA. (1987) Schizotypal personality disorder: A poor prognostic indicator for behavior therapy in the treatment of obsessive-compulsive disorder. J Anxiety Disord, 1, pp. 273-276.
57. Baer, L., Jenike, MA, Black, DW, Treece, C., Rosenfeld, R. and Greist, J. (1992) Effects of Axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. Arch Gen Psychiatry, 49, pp. 862-866.
58. Moritz, S., Fricke, S. Jacobsen, D. et al. (2004) Positive schizotypal symptoms predict treatment outcome in obsessive-compulsive disorder. Behav Res Ther, 42, pp. 217-227.
59. Leonard, HL, Swedo, SE Lenane, MC et al. (1993) A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents. Arch Gen Psychiatry, 50, pp. 429-439.
60. McDougle, CJ, Goodman, WK, Leckman, JF, Barr, LC, Heninger, GR and Price, LH. (1993) The efficacy of fluvoxamine in obsessive-compulsive disorder: Effects of comorbid chronic tic disorder. J Clin Psychopharmacol, 13, pp. 354-358.
61. McDougle, CJ, Goodman, WK, Leckman, JF, Lee, NC, Heninger, GR and Price, LH. (1994) Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: A double-blind placebo-controlled study in patients with and without tics. Arch Gen Psychiatry, 51, pp. 302-308.
62. Foa, EB. (1979) Failure in treating obsessive-compulsives. Behav Res Ther, 17, pp. 169-176.
63. Goodman, WK, Price, LH Delgado, PL et al. (1990) Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: Comparison of fluvoxamine and desipramine. Arch Gen Psychiatry, 47, pp. 577-585.
64. Overbeek, T., Schruers, K., Vermetten, E. and Griez, E. (2002) Comorbidity of obsessive-compulsive disorder and depression: Prevalence, symptom severity, and treatment effect. J Clin Psychiatry, 63, pp. 1106-1112.
65. Lochner, C., Kinnear, CJ Hemmings, SMJ et al. (2005) Hoarding in obsessive-compulsive disorder: Clinical and genetic correlates. J Clin Psychiatry, 66, pp. 1155-1160.
66. Samuels, JF, Bienvenu, OJ Pinto, A. et al. (2007) Hoarding in obsessive-compulsive disorder: Results from the OCD Collaborative Genetics Study. Behav Res Ther, 45, pp. 673-686.
67. Damecour, CL and Charron, M. (1998) Hoarding: A symptom, not a syndrome. J Clin Psychiatry, 59, pp. 267-272.
68. Frost, RO, Steketee, G., Williams, LF and Warren, R. (2000) Mood, personality disorder symptoms and disability in obsessive-compulsive hoarders: A comparison with clinical and nonclinical controls. Behav Res Ther, 38, pp. 1071-1081.
69. Steketee, G. and Frost, RO. (2006) Compulsive hoarding and acquiring: therapist guide, Oxford University Press, Oxford
70. Hollander, E., Rossi, NB, Sood, E. and Pallanti, S. (2003) Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: A double-blind, placebo-controlled study. Int J Neuropsychopharmacol, 6, pp. 397-401.
71. McDougle, CJ, Goodman, WK, Price, LH, Delgado, PL, Krystal, JH and Charney, DS. (1990) Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry, 147, pp. 652-654.
72. Bogetto, F., Bellino, S., Vaschetto, P. and Ziero, S. (2000) Olanzapine augmentation in fluvoxamine-refractory obsessive-compulsive disorder: A 12-week open trial. Psychiatry Res, 96, pp. 91-98.
73. Stein, DJ, Seedat, S. and Potocnik, F. (1999) Hoarding: A review. Isr J Psychiatry Relat Sci, 36, pp. 35-46.
74. Freeston, MH, Rheaume, J. and Ladouceur, R. (1996) Correcting faulty appraisals of obsessional thoughts. Behav Res Ther, 34, pp. 433-446.
75. Obsessive Compulsive Cognitions Working Group (1997) Cognitive assessment of obsessive-compulsive disorder. Behav Res Ther, 35, pp. 667-681.
76. Shafran, R., Thordarson, DS and Rachman, S. (1996) Thought-action fusion in obsessive-compulsive disorder. J Anxiety Disord, 10, pp. 379-391.
77. Rachman, S. (2003) The treatment of obsessions, Oxford University Press, Oxford
78. Freeston, MH, Ladouceur, R. Gagnon, F. et al. (1997) Cognitive-behavioral treatment of obsessive thoughts: A controlled study. J Consult Clin Psychol, 65, pp. 405-413.
79. O'Connor, K., Freeston, MH Gareau, D. et al. (2005) Group versus individual treatment in obsessions without compulsions. Clin Psychol Psychother, 12, pp. 87-96.
80. Mayerovitch, JI, du Fort, GG, Kakuma, R., Bland, RC, Newman, SC and Pinard, G. (2003) Treatment seeking for obsessive-compulsive disorder: role of obsessive-compulsive disorder symptoms and comorbid psychiatric diagnoses. Compr Psychiatry, 44, pp. 162-168.
81. Eisen, JL, Coles, ME Shea, TT et al. (2006) Clarifying the convergence between obsessive-compulsive personality disorder criteria and obsessive-compulsive disorder. J Pers Disord, 20, pp. 294-305.
82. Sobin, C., Blundell, ML and Karayiorgou, M. (2000) Phenotypic differences in early- and late-onset obsessive-compulsive disorder. Compr Psychiatry, 41, pp. 373-379.
83. Tukel, R., Ertekin, E. Batmaz, S. et al. (2005) Influence of age of onset on clinical features in obsessive-compulsive disorder. Depress Anxiety, 21, pp. 112-117.
84. Baer, L. (1994) Factor analysis of symptom subtypes of obsessive-compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry, 55, pp. 18-23.
85. Leckman, JF, Walker, DE, Goodman, WK, Pauls, DL and Cohen, DJ. (1994) "Just right" perceptions associated with compulsive behavior in Tourette's syndrome. Am J Psychiatry, 151, pp. 675-680.
86. Leckman, JF, Grice, DE Barr, LC et al. (1995) Tic-related vs. non-tic related obsessive-compulsive disorder. Anxiety, 1, pp. 208-215.
87. Pitman, RK. (1987) Pierre Janet on obsessive-compulsive disorder 1903. Review and commentary. Arch Gen Psychiatry, 44, pp. 226-232.
88. Miguel, EC, do Rosario-Campos, MC da Silva Prado, H et al. (2000) Sensory phenomena in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry, 61, pp. 150-156.
89. Coles, ME, Frost, RO, Heimberg, RG and Rheaume, J. (2003) "Not just right experiences": Perfectionism, obsessive-compulsive features and general psychopathology. Behav Res Ther, 41, pp. 681-700.
90. Summerfeldt, LJ. (2004) Understanding and treating incompleteness in obsessive-compulsive disorder. J Clin Psychol, 60, pp. 1155-1168.
91. McDougle, CJ, Epperson, CN, Pelton, GH, Wasylink, S. and Price, LH. (2000) A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry, 57, pp. 794-801.
92. Azrin, NH and Nunn, RG. (1973) Habit reversal: A method for eliminating nervous habits and tics. Behav Res Ther, 11, pp. 619-628.
93. Baer, L., Rauch, SL Ballantine, HT et al. (1995) Cingulotomy for intractable obsessive-compulsive disorder: Prospective long-term follow-up of 18 patients. Arch Gen Psychiatry, 52, pp. 384-392.
94. Tsao, S. and McKay, D. (2004) Behavioral avoidance tests and disgust in contamination fear: Distinctions from trait anxiety. Behav Res Ther, 42, pp. 207-216.
95. McKay, D. (2006) Treating disgust reactions in contamination-based obsessive-compulsive disorder. J Behav Ther Exp Psychiatry, 37, pp. 53-59.
96. Jones, MK and Menzies, RG. (1998) Danger ideation reduction therapy (DIRT) for obsessive-compulsive washers: A controlled trial. Behav Res Ther, 36, pp. 959-970.
97. Krochmalik, A., Jones, MK and Menzies, RG. (2001) Danger Ideation Reduction Therapy (DIRT) for treatment-resistant compulsive washing. Behav Res Ther, 39, pp. 897-912.
98. Denys, D., de Geus, F., van Megen, HJGM and Westenberg, HGM. (2004) A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry, 65, pp. 1040-1048.
99. Greist, JH. (1992) An integrated approach to treatment of obsessive-compulsive disorder. J Clin Psychiatry, 53, pp. 38-41.
100. Rachman, SJ and Hodgson, RJ. (1980) Obsessions and compulsions, Prentice Hall, New York
101. Foa, EB, Steketee, GS and Ozarow, BJ. (1985) Behavior therapy with obsessive compulsives: From theory to treatment. Obsessive compulsive disorder: Psychological and pharmacological treatments, pp. 49-129. Plenum Press, New York
102. Fisher, PL and Wells, A. (2005) How effective are cognitive and behavioral treatments for obsessive-compulsive disorder? A clinical significance analysis. Behav Res Ther, 43, pp. 1543-1558.
103. Salkovskis, PM. (1985) Obsessional-compulsive problems: A cognitive-behavioural analysis. Behav Res Ther, 23, pp. 571-583.
104. Rachman, S. (2002) A cognitive theory of compulsive checking. Behav Res Ther, 40, pp. 625-639.
105. Tolin, DF, Abramowitz, JS, Brigidi, BD and Foa, EB. (2003) Intolerance of uncertainty in obsessive-compulsive disorder. J Anxiety Disord, 17, pp. 233-242.
106. van den Hout, M and Kindt, M. (2003) Repeated checking causes memory distrust. Behav Res Ther, 41, pp. 301-316.
107. Clark, DA. (2005) Lumping versus splitting: A commentary on subtyping in OCD. Behav Ther, 36, pp. 401-404.
108. Anholt, GE, Kempe, P. de Haan, E. et al. (2008) Cognitive versus behavior therapy: Processes of change in the treatment of obsessive-compulsive disorder. Psychother Psychosom, 77, pp. 38-42.
109. Hofmann, SG. (2008) Cognitive processes during fear acquisition and extinction in animals and humans: Implications for exposure therapy of anxiety disorders. Clin Psychol Rev, 28, pp. 200-211.